Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma

Lymphoma
30/08/2020

Pediatr Blood Cancer. 2020 Aug 29:e28460. doi: 10.1002/pbc.28460. Online ahead of print.

NO ABSTRACT